BBLGW Bone Bio quarterly earnings carry no finalized public metrics as the firm wraps up internal financial reviews Fed Chair Nominee Confirmation Hearing and Monetary Policy Outlook CBFV CB Financial reports 132 Q4 2025 EPS miss with shares posting a negligible 003 dip in todays trading session RPD Rapid7 Q4 2025 results beat EPS forecasts shares rise 361 percent on steady year over year revenue growth